Intuitive Surgical Pre-Tax Profit Margin 2010-2025 | ISRG
Current and historical pre-tax profit margin for Intuitive Surgical (ISRG) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Intuitive Surgical pre-tax profit margin for the three months ending March 31, 2025 was .
| Intuitive Surgical Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $8.72B | $2.81B | 32.19% |
| 2024-12-31 | $8.35B | $2.68B | 32.02% |
| 2024-09-30 | $7.87B | $2.38B | 30.27% |
| 2024-06-30 | $7.57B | $2.23B | 29.47% |
| 2024-03-31 | $7.32B | $2.08B | 28.36% |
| 2023-12-31 | $7.12B | $1.96B | 27.50% |
| 2023-09-30 | $6.85B | $1.84B | 26.83% |
| 2023-06-30 | $6.66B | $1.72B | 25.80% |
| 2023-03-31 | $6.43B | $1.63B | 25.30% |
| 2022-12-31 | $6.22B | $1.61B | 25.83% |
| 2022-09-30 | $6.12B | $1.67B | 27.23% |
| 2022-06-30 | $5.96B | $1.72B | 28.91% |
| 2022-03-31 | $5.91B | $1.84B | 31.21% |
| 2021-12-31 | $5.71B | $1.89B | 33.10% |
| 2021-09-30 | $5.49B | $1.87B | 34.13% |
| 2021-06-30 | $5.16B | $1.77B | 34.22% |
| 2021-03-31 | $4.55B | $1.35B | 29.62% |
| 2020-12-31 | $4.36B | $1.21B | 27.69% |
| 2020-09-30 | $4.31B | $1.20B | 27.90% |
| 2020-06-30 | $4.36B | $1.25B | 28.59% |
| 2020-03-31 | $4.61B | $1.53B | 33.25% |
| 2019-12-31 | $4.48B | $1.50B | 33.56% |
| 2019-09-30 | $4.25B | $1.43B | 33.66% |
| 2019-06-30 | $4.04B | $1.37B | 33.80% |
| 2019-03-31 | $3.85B | $1.27B | 32.98% |
| 2018-12-31 | $3.73B | $1.28B | 34.36% |
| 2018-09-30 | $3.57B | $1.26B | 35.35% |
| 2018-06-30 | $3.46B | $1.22B | 35.23% |
| 2018-03-31 | $3.31B | $1.19B | 36.04% |
| 2017-12-31 | $3.14B | $1.10B | 35.17% |
| 2017-09-30 | $3.01B | $1.04B | 34.73% |
| 2017-06-30 | $2.88B | $1.02B | 35.40% |
| 2017-03-31 | $2.79B | $1.00B | 35.92% |
| 2016-12-31 | $2.71B | $0.99B | 36.42% |
| 2016-09-30 | $2.63B | $0.96B | 36.46% |
| 2016-06-30 | $2.53B | $0.88B | 34.91% |
| 2016-03-31 | $2.45B | $0.81B | 33.05% |
| 2015-12-31 | $2.39B | $0.76B | 31.82% |
| 2015-09-30 | $2.31B | $0.69B | 29.92% |
| 2015-06-30 | $2.27B | $0.66B | 28.99% |
| 2015-03-31 | $2.20B | $0.62B | 28.38% |
| 2014-12-31 | $2.13B | $0.55B | 25.80% |
| 2014-09-30 | $2.10B | $0.58B | 27.58% |
| 2014-06-30 | $2.05B | $0.60B | 29.09% |
| 2014-03-31 | $2.12B | $0.68B | 31.95% |
| 2013-12-31 | $2.27B | $0.87B | 38.50% |
| 2013-09-30 | $2.30B | $0.91B | 39.56% |
| 2013-06-30 | $2.34B | $0.95B | 40.52% |
| 2013-03-31 | $2.30B | $0.95B | 41.53% |
| 2012-12-31 | $2.18B | $0.89B | 41.03% |
| 2012-09-30 | $2.07B | $0.85B | 40.88% |
| 2012-06-30 | $1.98B | $0.81B | 40.99% |
| 2012-03-31 | $1.87B | $0.75B | 40.38% |
| 2011-12-31 | $1.76B | $0.71B | 40.39% |
| 2011-09-30 | $1.65B | $0.66B | 40.24% |
| 2011-06-30 | $1.55B | $0.62B | 40.08% |
| 2011-03-31 | $1.47B | $0.59B | 40.22% |
| 2010-12-31 | $1.41B | $0.57B | 40.48% |
| 2010-09-30 | $1.35B | $0.55B | 40.68% |
| 2010-06-30 | $1.28B | $0.52B | 40.53% |
| 2010-03-31 | $1.19B | $0.48B | 40.32% |
| 2009-12-31 | $1.05B | $0.40B | 37.74% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $201.298B | $8.352B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $156.252B | 18.90 |
| Edwards Lifesciences (EW) | United States | $45.778B | 30.01 |
| Alcon (ALC) | Switzerland | $44.076B | 29.79 |
| IDEXX Laboratories (IDXX) | United States | $41.955B | 48.21 |
| DexCom (DXCM) | United States | $34.098B | 52.70 |
| IQVIA Holdings (IQV) | United States | $24.832B | 13.91 |
| STERIS (STE) | Ireland | $24.813B | 27.36 |
| Mettler-Toledo (MTD) | United States | $24.089B | 28.65 |
| Waters (WAT) | United States | $21.336B | 30.10 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.297B | 0.00 |
| Hologic (HOLX) | United States | $12.575B | 13.66 |
| Penumbra (PEN) | United States | $10.904B | 85.58 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $8.397B | 19.69 |
| Teleflex (TFX) | United States | $5.662B | 9.35 |
| Glaukos (GKOS) | United States | $5.477B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.238B | 22.20 |
| TransMedics (TMDX) | United States | $4.130B | 89.78 |
| PROCEPT BioRobotics (PRCT) | United States | $3.280B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.398B | 14.28 |
| Veracyte (VCYT) | United States | $2.271B | 31.87 |
| Nihon Kohden (NHNKY) | Japan | $2.119B | 24.30 |
| Elekta AB (EKTAY) | Sweden | $2.079B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $1.905B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.514B | 0.00 |
| Artivion (AORT) | United States | $1.269B | 118.84 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.053B | 5.60 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| IRadimed (IRMD) | United States | $0.689B | 34.97 |
| RxSight (RXST) | United States | $0.663B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.655B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.644B | 14.08 |
| Delcath Systems (DCTH) | United States | $0.630B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.601B | 9.35 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.557B | 0.00 |
| AxoGen (AXGN) | United States | $0.536B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 12.84 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.471B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.367B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.218B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Inogen (INGN) | United States | $0.165B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.127B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| EDAP TMS S.A (EDAP) | France | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.069B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.064B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.049B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.66 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |